← Case indexGOW
Let's Gowex (BME MAB: GOW)
Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.
| Key Fact | Detail |
|---|---|
| Report | Forensic Short — Closed Case |
| Publication date | August 1, 2014 |
| Issuer | Let's Gowex S.A. (Spanish municipal-Wi-Fi issuer; defunct) |
| Ticker | BME (MAB): GOW |
| Original short | Gotham City Research — "Gowex: A Pescanova in Sheep's Clothing" (July 1, 2014) |
| Headline post-publication events | CEO Jenaro García confesses to fraud (July 6, 2014); company files for bankruptcy (July 6, 2014); shares suspended; Spanish criminal proceedings; civil-litigation recoveries through Spanish courts |
| Rating | SHORT — Closed Case (equity extinguished; CEO confessed) |
Why We Are Publishing Today
Let's Gowex is the fastest-confessed forensic-short case in the modern catalogue. The original short publication landed on July 1, 2014; five days later — July 6, 2014 — founder and CEO Jenaro García publicly confessed that the company's accounts had been falsified for years, and the company filed for bankruptcy. The case remains the cleanest, fastest closure of any modern European forensic short and is the genre's canonical confession.
This Closed Case write-up consolidates the public record from the original short publication through the Spanish criminal dispositions.
Section 1 — The Thesis (As Of July 2014)
Our reading of Gowex, at the time the issuer was first publicly questioned, identified three core deficiencies — set against the contemporaneous Spanish Pescanova accounting fraud as comparative context:
- Reported revenue that materially exceeded what the disclosed municipal-Wi-Fi customer base could plausibly generate, supported by detailed bottom-up estimates of plausible revenue across the disclosed customer footprint;
- Related-party transactions with affiliated entities controlled by management to generate the appearance of third-party revenue;
- Listing on a relatively-lightly-regulated venue (BME's MAB, the Spanish alternative market) with reduced disclosure and audit standards relative to the main board.
The thesis drew on customer-by-customer revenue triangulation work.
Section 2 — The García Confession (July 6, 2014)
The post-publication sequence was the fastest in modern European forensic-short history:
- July 1, 2014. Original short publication. Trading on the MAB is volatile.
- July 2–5, 2014. Gowex publicly disputes the allegations.
- July 6, 2014. Jenaro García publicly confesses that Gowex's accounts had been falsified for at least the previous four years and that the disclosed revenue and customer figures were substantially fabricated. The company files for bankruptcy the same day. Shares are suspended.
The confession came via García's personal social-media disclosure, an unusually-direct admission for a sitting public-company CEO.
Section 3 — Bankruptcy and Spanish Criminal Proceedings
Through 2014–2018:
- Gowex entered Spanish insolvency proceedings; recoveries for shareholders were minimal;
- Spanish criminal proceedings against García on charges including fraud, false-accounting and market manipulation advanced through Spanish courts;
- García pled guilty in subsequent proceedings; sentencing materials are part of the Spanish court record.
Investor-recovery channels worked through Spanish civil-litigation routes against García, former officers and ancillary parties.
Section 4 — Where Things Stand And What We Take From The Case
As of this writing:
- Let's Gowex is defunct; the listing is extinguished.
- Spanish criminal proceedings against named individuals are substantively closed.
- BME / MAB has subsequently strengthened its issuer-level disclosure requirements; the post-Gowex regulatory response is part of the case's continuing legacy.
What we take from the Gowex case:
- It is the canonical confession case. Five days from publication to CEO confession is, to our knowledge, the shortest such window in the modern forensic-short genre.
- Bottom-up customer revenue triangulation is highly probative. Modeling plausible revenue across the disclosed customer base and identifying the gap remains a useful diagnostic for issuers whose customer footprint is disclosed but whose revenue does not match plausible per-customer economics.
- Lightly-regulated alternative venues warrant heightened scrutiny. Gowex's listing on the MAB rather than the BME main board was, on the available record, materially correlated with the disclosure deficiencies the case ultimately revealed. The post-Gowex Spanish regulatory response — strengthening MAB requirements — partially addresses this gap.
Source Index (selected)
- Jenaro García public confession statement, July 6, 2014.
- Spanish bankruptcy court — Let's Gowex S.A. insolvency proceedings.
- Spanish criminal court — proceedings against Jenaro García and co-defendants.
- BME / MAB subsequent disclosure-rule revisions.
— Muddy Insights, August 1, 2014.
// More files
- 0282026-10-21CURRCURR · 2026-10-21Currenc Group Inc. (NASDAQ: CURR) — Forensic FileA Charging Order Over The Only Asset That Matters. The Same 100,465 Tranglo Shares Sold For US$400M Are Now Charged To A Judgment Creditor.NOT RATED — Forensic FileNOT RATED — Forensic File
- 0272026-07-21DLXYDLXY · 2026-07-21Delixy Holdings Ltd. (NASDAQ: DLXY) — Forensic Short ReportThe IPO Funded An Exit, Not An Expansion. Dividends Out 4x What The Public Put In.NOT RATED — Research case studyNOT RATED — Research case study
- 0262026-07-15TROOTROO · 2026-07-15TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateThe August 20 Endgame: Winding-Up Exposure, Suspension Mechanics, And A Support Bid Running On FumesSHORT — High convictionSHORT — High conviction
- 0252026-05-15ADANIENTADANIENT · 2026-05-15Adani Enterprises (NSE: ADANIENT)Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.SHORT — UpdateSHORT — Update
- 0242026-05-05TROOTROO · 2026-05-05TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateAuditor Replaced. Lock-Up Eased. Annual Report Past Due.SHORT — High convictionSHORT — High conviction
- 0232026-04-15TRETRE · 2026-04-15Sino-Forest Corporation (TSX: TRE)The founding case of the modern China-short genre — fifteen years on.SHORT — Closed CaseSHORT — Closed Case
- 0222026-03-30BURBUR · 2026-03-30Burford Capital (NYSE/LSE: BUR)Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.NEUTRALNEUTRAL
- 0212026-02-25IEPIEP · 2026-02-25Icahn Enterprises L.P. (NASDAQ: IEP)Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.SHORT — UpdateSHORT — Update
- 0202026-02-01WDIWDI · 2026-02-01Wirecard AG (XETRA: WDI) — Closed-Case RetrospectiveSix years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.SHORT — Closed CaseSHORT — Closed Case
- 0192026-01-15NKLANKLA · 2026-01-15Nikola Corporation (NASDAQ: NKLA)The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.SHORT — Closed CaseSHORT — Closed Case
- 0182025-12-02MAGHMAGH · 2025-12-02Magnitude International Ltd. (NASDAQ: MAGH) — Forensic ShortPenny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.SHORT — High convictionSHORT — High conviction
- 0172025-10-21VRXVRX · 2025-10-21Valeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.SHORT — Closed CaseSHORT — Closed Case
- 0162025-09-01TIOTIO · 2025-09-01Tingo Group (NASDAQ: TIO)Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.SHORT — Closed CaseSHORT — Closed Case
- 0152024-09-15EBIXEBIX · 2024-09-15Ebix, Inc. (NASDAQ: EBIX)Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.SHORT — UpdateSHORT — Update
- 0142024-07-15FFGRPFFGRP · 2024-07-15Folli Follie (ATHEX: FFGRP)QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.SHORT — Closed CaseSHORT — Closed Case
- 0132024-04-15SNHSNH · 2024-04-15Steinhoff International (JSE: SNH)Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.SHORT — Closed CaseSHORT — Closed Case
- 0122024-04-01RIDERIDE · 2024-04-01Lordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.SHORT — Closed CaseSHORT — Closed Case
- 0112022-09-15GSXGSX · 2022-09-15GSX Techedu (NYSE: GSX, now Gaotu: GOTU)Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.SHORT — Closed CaseSHORT — Closed Case
- 0102022-05-15EROSEROS · 2022-05-15Eros International / Eros STX Global (NYSE: EROS, formerly)Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.SHORT — Closed CaseSHORT — Closed Case
- 0092021-09-15QPPQPP · 2021-09-15Quindell PLC (LSE AIM: QPP, now Watchstone)Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.SHORT — Closed CaseSHORT — Closed Case
- 0082020-10-15SONGSONG · 2020-10-15Akazoo S.A. (NASDAQ: SONG)QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.SHORT — Closed CaseSHORT — Closed Case
- 0072020-02-15INSYINSY · 2020-02-15Insys Therapeutics (NASDAQ: INSY)Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.SHORT — Closed CaseSHORT — Closed Case
- 0062020-01-15ONON · 2020-01-15Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed CaseAuditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.SHORT — Closed CaseSHORT — Closed Case
- 0052019-01-15N21N21 · 2019-01-15Noble Group (SGX: N21)Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.SHORT — Closed CaseSHORT — Closed Case
- 0042018-01-15NQNQ · 2018-01-15NQ Mobile (NYSE: NQ)Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.SHORT — Closed CaseSHORT — Closed Case
- 0032015-09-15FMCNFMCN · 2015-09-15Focus Media (NASDAQ: FMCN, formerly)Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.SHORT — Counter-CaseSHORT — Counter-Case
- 0022013-12-15CCMECCME · 2013-12-15China MediaExpress Holdings (NASDAQ: CCME)Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.SHORT — Closed CaseSHORT — Closed Case
- 0012013-12-15LFTLFT · 2013-12-15Longtop Financial Technologies (NYSE: LFT)Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.SHORT — Closed CaseSHORT — Closed Case